Drugs Online » Prescription Drugs 1 » ACOMPLIA Generic Rimonabant
Appetite suppressant Anti obesity drug. Acomplia is used complementary to diet and exercise to treat .obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the bloodA single pill has been found to stop both food and cigarette cravings enough to help people quit smoking and lose weight and could also help curb other unhealthy urges. In one study the medicine helped people who were overweight drop an average of 20 pounds and in another doubled the chances that smokers would quit. Acomplia contains the active ingredient Rimonabant. It is a selective CB1 Endocannabinoid Receptor Antagonist.Acomplia works by blocking receptors of a substance called cannabinoid 1 which stimulates hunger and other cravings in the brain and is also present in fat tissue. Sanofi argues that Acomplia can also prevent the risk ofCardiovascular disease.Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the drug.ACOMPLIAŤ (rimonabant) approved as an adjunct to diet and exercise for the treatment of obese patients (BMI ≥ 30 kg/m2) or overweight patients (BMI > 27 kg/m2) with associated risk factors such as type 2 diabetes or dyslipidemia.Side Effects:Acomplia was said to be well tolerated in early tests. The only relatively common side effects were mild GI side effects and dizziness and these were said to be transient.
Buy ACOMPLIA Generic Rimonabant and other Prescription Drugs 1 products online
at Medstore.
Buy Online at Medstore - Click Here!

About ACOMPLIA Generic Rimonabant:
Product Type: Prescription Drugs 1
ACOMPLIA ( Generic Rimonabant )
ACOMPLIA (Generic Rimonabant)
Generic Rimonabant
20mg 28 Tabs 20mg 56 Tabs
Generic Rimonabant ACOMPLIA

View more
Prescription Drugs 1
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|